miR‐574‐5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES‐1 induction

2019 ◽  
Vol 33 (6) ◽  
pp. 6933-6947 ◽  
Author(s):  
Meike J. Saul ◽  
Isabell Baumann ◽  
Annalisa Bruno ◽  
Anne C. Emmerich ◽  
Julia Wellstein ◽  
...  
2009 ◽  
Vol 27 (15_suppl) ◽  
pp. 2537-2537 ◽  
Author(s):  
P. Phillips ◽  
M. Yalcin ◽  
H. Cui ◽  
H. H. Abdel-Nabi ◽  
M. Sajjad ◽  
...  

2537 Thrombotic complications are the second most common cause of mortality in cancer patients and fibrin deposition in the tumor microenvironment might play a key role in tumor progression and inference with tumor chemotherapeutic uptake. Treatments that target these processes may result in improved uptake of chemotherapeutic agents and subsequent inhibition of tumor growth and metastasis. Tissue Factor (TF) is frequently associated with aggressive behavior and poor outcome in tumors. We have previously demonstrated potent anti-tumor efficacy for various mechanisms that interfere with TF/VIIa. The purpose of this study was to investigate the effects of low molecular weight heparins (LMWH) and sulfated non-anticoagulant LMWH (S-NACH) on tumor chemotherapeutic uptake. Studies: (1) Nude mice xenograft A549 human lung carcinoma: LMWH or S-NACH at 10 mg/kg S.C. daily effectively limited tumor growth. (2) LCC6 human lung tumor xenograft model: Paclitaxel alone or in combination with Tinzaparin or S-NACH on tumor re-growth after discontinuation of treatment: Paclitaxel + S-NACH treatment showed significant (P<0.01) tumor growth suppression and improved survival when compared to Paclitaxel. (3) Biodistribution studies: animals were injected with LMWH S.C. daily for 5 days (10 mg/kg) then injected i.v. with [124-I]-Paclitaxel. LMWH increased [124-I]-Paclitaxel uptake into LCC6 tumors with tumor: muscle ratios several fold greater than that of [124-I]-Paclitaxel alone at 24 hrs post injection. This is a highly significant result in the light of the fact that the FDA criterion for a clinically meaningful effect is a 15% increase in uptake. (4) HPLC studies of tumor uptake of Doxorubicin (DOX in mice treated with 10 mg/kg of LMWH or S-NACH for 10 days followed by Doxorubicin (2.5 mg/kg). Both LMWH and S-NACH significantly (P<0.01) increased the uptake of chemotherapeutic agent DOX in MCF7 DOX resistant tumors by 1.5–2 folds but not in heart or lung tissues, confirming the findings obtained with another agent [124-I]-Paclitaxel. Conclusions: LMWH or S-NACH increased chemotherapeutics uptake and hence chemoresponse. Protocols utilizing adjuvant or neo-adjuvant therapy with LMWH or S-NACH could lead to increase tumor chemo responsiveness and overcoming tumor chemo resistance. No significant financial relationships to disclose.


Author(s):  
Shanbeh Zienolddiny ◽  
David Ryberg ◽  
Adi F. Gazdar ◽  
Aage Haugen

2007 ◽  
Vol 179 (2) ◽  
pp. 733-733
Author(s):  
Michael R. Nazareth ◽  
Lori Broderick ◽  
Michelle R. Simpson-Abelson ◽  
Raymond J. Kelleher ◽  
Sandra J. Yokota ◽  
...  

1989 ◽  
Author(s):  
E. Benedetti ◽  
L. Teodori ◽  
P. Vergamini ◽  
M. L. Trinca ◽  
F. Mauro ◽  
...  

1997 ◽  
Vol 16 (3) ◽  
pp. 257-268 ◽  
Author(s):  
A.M. SCHULTE ◽  
S. FISCHER ◽  
G.E. SACHSE ◽  
S. HÄ"FNER ◽  
S. STELCK ◽  
...  

1989 ◽  
Vol 108 (6) ◽  
pp. 2423-2434 ◽  
Author(s):  
R T Rivera ◽  
S G Pasion ◽  
D T Wong ◽  
Y B Fei ◽  
D K Biswas

A clonal strain of human lung tumor cells in culture (ChaGo), derived from a bronchogenic carcinoma, synthesizes and secretes large amounts of alpha (alpha) and a comparatively lower level of beta (beta) subunit of the glycoprotein hormone, human chorionic gonadotropin (HCG). ChaGo cells lost their characteristic anchorage-independent growth phenotype in the presence of anti-alpha-HCG antibody. The effect of the antibody was partially reversed by addition of alpha-HCG to the culture medium. ChaGo cells were transfected with an expression vector (pRSV-anti-alpha-HCG), that directs synthesis of RNA complementary to alpha-HCG mRNA. The transfectants produced alpha-HCG antisense RNA which was associated with the reduced level of alpha-HCG. Transfectants also displayed several altered phenotypic properties, including altered morphology, less mitosis, reduced growth rate, loss of anchorage-independent growth, and loss of tumorigenicity in nude mice. Treatment of transfectants with 8,bromo-cAMP resulted in increased accumulation of alpha-HCG mRNA, no change in the level of alpha-HCG antisense RNA, release of the inhibition of [3H]thymidine incorporation, and restoration of anchorage-independent growth phenotype. The overexpression of c-myc, observed in ChaGo cells, was unaffected by the reduced level of alpha-HCG. These results suggest that ectopic synthesis of the alpha subunit of HCG plays a functional role in the transformation of these human lung cells.


1993 ◽  
Vol 53 (3) ◽  
pp. 514-520 ◽  
Author(s):  
R. Seitz ◽  
H.-H. Heidtmann ◽  
M. Maasberg ◽  
A. Immel ◽  
R. Egbring ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document